BIOMAT Database Logo BIOMAT Database Logo

Identification of a novel "almost neutral" micro-opioid receptor antagonist in CHO cells expressing the cloned human mu-opioid receptor. 2010

Elliott J Sally, and Heng Xu, and Christina M Dersch, and Ling-Wei Hsin, and Li-Te Chang, and Thomas E Prisinzano, and Denise S Simpson, and Denise Giuvelis, and Kenner C Rice, and Arthur E Jacobson, and Kejun Cheng, and Edward J Bilsky, and Richard B Rothman
Clinical Psychopharmacology Section, IRP, NIDA, NIH, DHHS, Baltimore, Maryland 21224, USA.

The basal (constitutive) activity of G protein-coupled receptors allows for the measurement of inverse agonist activity. Some competitive antagonists turn into inverse agonists under conditions where receptors are constitutively active. In contrast, neutral antagonists have no inverse agonist activity, and they block both agonist and inverse agonist activity. The mu-opioid receptor (MOR) demonstrates detectable constitutive activity only after a state of dependence is produced by chronic treatment with a MOR agonist. We therefore sought to identify novel MOR inverse agonists and novel neutral MOR antagonists in both untreated and agonist-treated MOR cells. CHO cells expressing the cloned human mu receptor (hMOR-CHO cells) were incubated for 20 h with medium (control) or 10 microM (2S,4aR,6aR,7R,9S,10aS,10bR)-9-(benzoyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho-[2,1-c]pyran-7-carboxylic acid methyl ester (herkinorin, HERK). HERK treatment generates a high degree of basal signaling and enhances the ability to detect inverse agonists. [(35)S]-GTP-gamma-S assays were conducted using established methods. We screened 21 MOR "antagonists" using membranes prepared from HERK-treated hMOR-CHO cells. All antagonists, including CTAP and 6beta-naltrexol, were inverse agonists. However, LTC-274 ((-)-3-cyclopropylmethyl-2,3,4,4alpha,5,6,7,7alpha-octahydro-1H-benzofuro[3,2-e]isoquinolin-9-ol)) showed the lowest efficacy as an inverse agonist, and, at concentrations less than 5 nM, had minimal effects on basal [(35)S]-GTP-gamma-S binding. Other efforts in this study identified KC-2-009 ((+)-3-((1R,5S)-2-((Z)-3-phenylallyl)-2-azabicyclo[3.3.1]nonan-5-yl)phenol hydrochloride) as an inverse agonist at untreated MOR cells. In HERK-treated cells, KC-2-009 had the highest efficacy as an inverse agonist. In summary, we identified a novel and selective MOR inverse agonist (KC-2-009) and a novel MOR antagonist (LTC-274) that shows the least inverse agonist activity among 21 MOR antagonists. LTC-274 is a promising lead compound for developing a true MOR neutral antagonist.

UI MeSH Term Description Entries
D009292 Narcotic Antagonists Agents inhibiting the effect of narcotics on the central nervous system. Competitive Opioid Antagonist,Narcotic Antagonist,Opioid Antagonist,Opioid Antagonists,Opioid Receptor Antagonist,Opioid Reversal Agent,Competitive Opioid Antagonists,Opioid Receptor Antagonists,Opioid Reversal Agents,Agent, Opioid Reversal,Agents, Opioid Reversal,Antagonist, Competitive Opioid,Antagonist, Narcotic,Antagonist, Opioid,Antagonist, Opioid Receptor,Antagonists, Competitive Opioid,Antagonists, Narcotic,Antagonists, Opioid,Antagonists, Opioid Receptor,Opioid Antagonist, Competitive,Opioid Antagonists, Competitive,Receptor Antagonist, Opioid,Receptor Antagonists, Opioid,Reversal Agent, Opioid,Reversal Agents, Opioid
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011753 Pyrones Keto-pyrans.
D003412 Cricetulus A genus of the family Muridae consisting of eleven species. C. migratorius, the grey or Armenian hamster, and C. griseus, the Chinese hamster, are the two species used in biomedical research. Hamsters, Armenian,Hamsters, Chinese,Hamsters, Grey,Armenian Hamster,Armenian Hamsters,Chinese Hamster,Chinese Hamsters,Grey Hamster,Grey Hamsters,Hamster, Armenian,Hamster, Chinese,Hamster, Grey
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005663 Furans Compounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran. Tetrahydrofurans
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000701 Analgesics, Opioid Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. Opioid,Opioid Analgesic,Opioid Analgesics,Opioids,Full Opioid Agonists,Opioid Full Agonists,Opioid Mixed Agonist-Antagonists,Opioid Partial Agonists,Partial Opioid Agonists,Agonist-Antagonists, Opioid Mixed,Agonists, Full Opioid,Agonists, Opioid Full,Agonists, Opioid Partial,Agonists, Partial Opioid,Analgesic, Opioid,Full Agonists, Opioid,Mixed Agonist-Antagonists, Opioid,Opioid Agonists, Full,Opioid Agonists, Partial,Opioid Mixed Agonist Antagonists,Partial Agonists, Opioid

Related Publications

Elliott J Sally, and Heng Xu, and Christina M Dersch, and Ling-Wei Hsin, and Li-Te Chang, and Thomas E Prisinzano, and Denise S Simpson, and Denise Giuvelis, and Kenner C Rice, and Arthur E Jacobson, and Kejun Cheng, and Edward J Bilsky, and Richard B Rothman
Anti-mu opioid antiserum against the third external loop of the cloned mu-opioid receptor acts as a mu receptor neutral antagonist.
November 2003, Brain research. Molecular brain research,
Elliott J Sally, and Heng Xu, and Christina M Dersch, and Ling-Wei Hsin, and Li-Te Chang, and Thomas E Prisinzano, and Denise S Simpson, and Denise Giuvelis, and Kenner C Rice, and Arthur E Jacobson, and Kejun Cheng, and Edward J Bilsky, and Richard B Rothman
Neutral antagonist activity of naltrexone and 6beta-naltrexol in naïve and opioid-dependent C6 cells expressing a mu-opioid receptor.
April 2009, British journal of pharmacology,
Elliott J Sally, and Heng Xu, and Christina M Dersch, and Ling-Wei Hsin, and Li-Te Chang, and Thomas E Prisinzano, and Denise S Simpson, and Denise Giuvelis, and Kenner C Rice, and Arthur E Jacobson, and Kejun Cheng, and Edward J Bilsky, and Richard B Rothman
Evidence for a mu-delta opioid receptor complex in CHO cells co-expressing mu and delta opioid peptide receptors.
August 2008, Peptides,
Elliott J Sally, and Heng Xu, and Christina M Dersch, and Ling-Wei Hsin, and Li-Te Chang, and Thomas E Prisinzano, and Denise S Simpson, and Denise Giuvelis, and Kenner C Rice, and Arthur E Jacobson, and Kejun Cheng, and Edward J Bilsky, and Richard B Rothman
Activity of opioid ligands in cells expressing cloned mu opioid receptors.
January 2003, BMC pharmacology,
Elliott J Sally, and Heng Xu, and Christina M Dersch, and Ling-Wei Hsin, and Li-Te Chang, and Thomas E Prisinzano, and Denise S Simpson, and Denise Giuvelis, and Kenner C Rice, and Arthur E Jacobson, and Kejun Cheng, and Edward J Bilsky, and Richard B Rothman
Characterization of the cloned human mu opioid receptor.
January 1995, The Journal of pharmacology and experimental therapeutics,
Elliott J Sally, and Heng Xu, and Christina M Dersch, and Ling-Wei Hsin, and Li-Te Chang, and Thomas E Prisinzano, and Denise S Simpson, and Denise Giuvelis, and Kenner C Rice, and Arthur E Jacobson, and Kejun Cheng, and Edward J Bilsky, and Richard B Rothman
Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptor.
January 2003, Synapse (New York, N.Y.),
Elliott J Sally, and Heng Xu, and Christina M Dersch, and Ling-Wei Hsin, and Li-Te Chang, and Thomas E Prisinzano, and Denise S Simpson, and Denise Giuvelis, and Kenner C Rice, and Arthur E Jacobson, and Kejun Cheng, and Edward J Bilsky, and Richard B Rothman
Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptors.
September 2008, Brain research bulletin,
Elliott J Sally, and Heng Xu, and Christina M Dersch, and Ling-Wei Hsin, and Li-Te Chang, and Thomas E Prisinzano, and Denise S Simpson, and Denise Giuvelis, and Kenner C Rice, and Arthur E Jacobson, and Kejun Cheng, and Edward J Bilsky, and Richard B Rothman
Endomorphins fully activate a cloned human mu opioid receptor.
November 1998, FEBS letters,
Elliott J Sally, and Heng Xu, and Christina M Dersch, and Ling-Wei Hsin, and Li-Te Chang, and Thomas E Prisinzano, and Denise S Simpson, and Denise Giuvelis, and Kenner C Rice, and Arthur E Jacobson, and Kejun Cheng, and Edward J Bilsky, and Richard B Rothman
[Expression of human mu-opioid receptor cDNA in CHO cell].
May 2004, Sheng wu gong cheng xue bao = Chinese journal of biotechnology,
Elliott J Sally, and Heng Xu, and Christina M Dersch, and Ling-Wei Hsin, and Li-Te Chang, and Thomas E Prisinzano, and Denise S Simpson, and Denise Giuvelis, and Kenner C Rice, and Arthur E Jacobson, and Kejun Cheng, and Edward J Bilsky, and Richard B Rothman
Up-regulation of RGS4 mRNA by opioid receptor agonists in PC12 cells expressing cloned mu- or kappa-opioid receptors.
December 2001, European journal of pharmacology,
Copied contents to your clipboard!